Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Runge

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1981
ATP-induced formation of an associated complex between microtubules and neurofilamentsM S Runge, T M Laue, D A Yphantis, et al.
Journal of the American College of Cardiology|June 7, 2000
Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomesC R deFilippi, M Tocchi, R J Parmar, et al.
The Journal of Clinical Investigation|November 21, 2001
p47phox is required for atherosclerotic lesion progression in ApoE(-/-) miceP A Barry-Lane, C Patterson, M van der Merwe, et al.
Circulation|February 18, 1997
Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targetingC Bode, S R Hanson, J F Schmedtje, et al.
Circulation|October 1, 1994
Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudinC Bode, M Hudelmayer, P Mehwald, et al.
The Journal of Biological Chemistry|July 3, 1999
Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivoC Patterson, J Ruef, N R Madamanchi, et al.
The American Journal of the Medical Sciences|October 1, 1992
Cloning and expression of a human endothelin receptor: subtype AD J Hayzer, P M Rose, J S Lynch, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 1991
A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivoM S Runge, T Quertermous, P J Zavodny, et al.
Circulation Research|July 1, 1997
Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosisJ Ruef, Z Y Hu, L Y Yin, et al.
Circulation|September 15, 1996
Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboonsM S Runge, L A Harker, C Bode, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1981
ATP-induced formation of an associated complex between microtubules and neurofilamentsM S Runge, T M Laue, D A Yphantis, et al.
Journal of the American College of Cardiology|June 7, 2000
Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomesC R deFilippi, M Tocchi, R J Parmar, et al.
The Journal of Clinical Investigation|November 21, 2001
p47phox is required for atherosclerotic lesion progression in ApoE(-/-) miceP A Barry-Lane, C Patterson, M van der Merwe, et al.
Circulation|February 18, 1997
Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targetingC Bode, S R Hanson, J F Schmedtje, et al.
Circulation|October 1, 1994
Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudinC Bode, M Hudelmayer, P Mehwald, et al.
The Journal of Biological Chemistry|July 3, 1999
Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivoC Patterson, J Ruef, N R Madamanchi, et al.
The American Journal of the Medical Sciences|October 1, 1992
Cloning and expression of a human endothelin receptor: subtype AD J Hayzer, P M Rose, J S Lynch, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 1991
A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivoM S Runge, T Quertermous, P J Zavodny, et al.
Circulation Research|July 1, 1997
Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosisJ Ruef, Z Y Hu, L Y Yin, et al.
Circulation|September 15, 1996
Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboonsM S Runge, L A Harker, C Bode, et al.
Pageof 14